Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Immunotherapy

Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy

Issei Saeki, Shigeo Shimose, Tetsu Tomonari, Takanori Ito, Joji Tani, Yasuto Takeuchi, Naoki Yoshioka, Takehito Naito, Mamiko Takeuchi, Satoru Kakizaki, Takeshi Hatanaka, Kyo Sasaki, Tetsuya Yasunaka, Masahiro Sakata, Hideki Iwamoto, Satoshi Itano, Tomotake Shirono, Norikazu Tanabe, Takafumi Yamamoto, Yuki Kanayama, Atsushi Naganuma, Sohji Nishina, Motoyuki Otsuka, Hideki Kobara, Hiroki Kawashima, Tetsuji Takayama, Takumi Kawaguchi, Takahiro Yamasaki, Taro Takami, Hepatology InVestigator Experts in Japan (HIVE-J) Study Group

published 25 Sep 2024

Loading metrics information...

Metrics unavailable. Please check back later.

G0 arrest gene patterns to predict the prognosis and drug sensitivity of patients with lung adenocarcinoma

Yong Ma, Zhilong Li, Dongbing Li, Baozhen Zheng, Yanfeng Xue

published 19 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors

Masaki Ito, Shigeo Koido, Takeo Iwamoto, Soyoko Morimoto, Fumihiro Fujiki, Haruo Sugiyama, Saki Matsumoto, Clara Effenberger, Kazuma Kiyotani, Kiyotaka Shiba

published 08 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Development of an in vivo syngeneic mouse transplant model of invasive intestinal adenocarcinoma driven by endogenous expression of Pik3ca^H1047R and Apc loss

Francesc de las Heras, Camilla B. Mitchell, William K. Murray, Nicholas J. Clemons, Wayne A. Phillips

published 02 Aug 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the context of the Chilean health care system

Nicolás Armijo, Constanza Salas, Nazareth Espinoza, Manuel Espinoza, Carlos Balmaceda

published 26 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Microbiota composition effect on immunotherapy outcomes in colorectal cancer patients: A systematic review

Suad Mohamed Ajab, Sumaya Hasan Zoughbor, Lena Abdulbaset Labania, Linda Mari Östlundh, Hiba Salaheldin Orsud, Marie Antonette Olanda, Obaid Alkaabi, Shamma Hamad Alkuwaiti, Shaikha Mohammed Alnuaimi, Zakeya Al Rasbi

published 24 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Efficacy comparison of immune combination therapies in subgroups for advanced hepatocellular carcinoma patients: Systematic review and network meta-analysis

Yani Wang, Wanyee Lau, Yafei Li, Yichen Tian, Yongrong Lei, Feng Xia, Jianhua Wang

published 22 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

ENCAP: Computational prediction of tumor T cell antigens with ensemble classifiers and diverse sequence features

Jen-Chieh Yu, Kuan Ni, Ching-Tai Chen

published 18 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

High-intensity focused ultrasound ablation combined with immunotherapy for treating liver metastases: A prospective non-randomized trial

Xiyue Yang, Yao Liao, Lingli Fan, Binwei Lin, Jie Li, Danfeng Wu, Dongbiao Liao, Li Yuan, Jihui Liu, Feng Gao, Gang Feng, Xiaobo Du

published 05 Jul 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Prognostic value of systemic immune-inflammation index/albumin ratio for immunotherapy-treated patients receiving opioids

Lei Yan, Pan Kang, Chengsong Cao, Bu Jinhui, Liu Yong

published 27 Jun 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation

Min Jeong Ahn, Eun Hye Kim, Yunha Choi, Chong Hak Chae, Pilho Kim, Seong Hwan Kim

published 26 Jun 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Particle swarm optimization solution for roll-off control in radiofrequency ablation of liver tumors: Optimal search for PID controller tuning

Rafael Mendes Faria, Suélia de Siqueira Rodrigues Fleury Rosa, Gustavo Adolfo Marcelino de Almeida Nunes, Klériston Silva Santos, Rafael Pissinati de Souza, Angie Daniela Ibarra Benavides, Angélica Kathariny de Oliveira Alves, Ana Karoline Almeida da Silva, Mario Fabrício Rosa, Antônio Aureliano de Anicêsio Cardoso, Sylvia de Sousa Faria, Enrique Berjano, Adson Ferreira da Rocha, Ícaro dos Santos, Ana González-Suárez

published 26 Jun 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Exploratory mapping of tumor associated macrophage nanoparticle article abstracts using an eLDA topic modeling machine learning approach

Chloe Brown, Colette S. M. Bilynsky, Melanie Gainey, Sarah Young, John Kitchin, Elizabeth C. Wayne

published 18 Jun 2024

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Immunotherapy

You can change these options by clicking profile then "Alerts and Notifications"